HEIA Methamphetamine Reagent MET for ImmTox 270 Toxicology

HEIA Methamphetamine Reagent MET for ImmTox 270 Toxicology

Benefits and Procedures of Using the HEIA Methamphetamine Reagent with the ImmTox 270 Machine

The HEIA (Homogeneous Enzyme Immunoassay) Methamphetamine Reagent, when paired with the ImmTox 270 Machine, provides a reliable, high-throughput solution for the qualitative detection of methamphetamine and related compounds in human biological samples such as urine or serum. This setup is widely used in clinical toxicology, forensic analysis, drug treatment centers, and workplace drug testing programs.

Key Benefits

1. High Specificity for Methamphetamine Class Drugs
The reagent is designed to detect methamphetamine and its structurally related compounds, including amphetamine, with minimal cross-reactivity to unrelated substances. This enhances screening accuracy and reduces the chance of false positives.

2. Fully Automated Testing with the ImmTox 270
The ImmTox 270 system automates the entire assay process—sample loading, reagent mixing, incubation, and result reading—resulting in increased productivity, reduced manual handling, and greater consistency between runs.

3. Fast Turnaround Time
The HEIA method enables rapid detection of methamphetamine, typically producing results within minutes. This is particularly valuable in emergency departments, legal settings, and rehabilitation facilities where timely information is critical.

4. Scalable for High-Volume Labs
With its automated workflow and ability to process large batches of samples, the ImmTox 270 is well-suited for labs handling high test volumes, helping streamline operations and reduce turnaround time.

5. Cost-Efficient and Low Maintenance
The HEIA platform requires fewer consumables and less maintenance compared to more complex confirmatory methods like GC-MS, making it a practical choice for routine screening.

6. CLIA and SAMHSA Compliance
The system is compatible with industry-standard cutoff concentrations (e.g., 500 ng/mL for methamphetamine in urine), ensuring it meets the regulatory needs of clinical and workplace testing environments.

Procedures for Use
Using the HEIA Methamphetamine Reagent with the ImmTox 270 involves the following key steps:

Sample Collection
A urine or serum sample is collected using standard procedures. Urine is the most common matrix for drug screening due to its detection window and non-invasive collection.

Loading the System 
Samples are placed into the designated trays of the ImmTox 270 analyzer. Reagents, calibrators, and controls are loaded into the system as per the test kit instructions.

Assay Execution 
The ImmTox 270 automates the immunoassay process. The reagent reacts with methamphetamine (if present) in the sample through a competitive binding process, resulting in a measurable change in absorbance.

Result Interpretation 
The system compares the test sample’s absorbance to that of a known cutoff calibrator. If the absorbance is less than or equal to the cutoff, the result is positive (methamphetamine detected). If it is greater than the cutoff, the result is negative (not detected or below threshold). Invalid results are flagged for repeat testing.

Reporting
Results are automatically documented and can be exported to a laboratory information system (LIS) or printed for manual review. Confirmatory testing using GC-MS may be recommended for positive screens.

The combination of the HEIA Methamphetamine Reagent and ImmTox 270 Machine provides a fast, accurate, and automated solution for initial drug screening. With high specificity, ease of use, and scalability, it is an ideal tool for labs seeking efficiency and reliability in toxicology testing.

Availability:
This product will be shipped overnight in 4-5 business days from receiving the order. This product will NOT ship on a Friday.